resources
Regulatory submissions
One2Treat is committed to revolutionizing clinical research leveraging the innovative GPC methodology, resulting of its extensive scientific research and clinical application spanning over 15 years.
Still, we recognize that we are not alone in advancing this methodology. Numerous pioneering companies have played a crucial role in making different versions of GPC accessible to trials and, ultimately, patients.
We would like to acknowledge and honor these trailblazers who boldly submitted their trials to regulatory authorities during the early stages of GPC industrialization. As a testament to their dedication, we provide a subset of these regulatory submissions, along with direct links to the FDA official database.
Still, we recognize that we are not alone in advancing this methodology. Numerous pioneering companies have played a crucial role in making different versions of GPC accessible to trials and, ultimately, patients.
We would like to acknowledge and honor these trailblazers who boldly submitted their trials to regulatory authorities during the early stages of GPC industrialization. As a testament to their dedication, we provide a subset of these regulatory submissions, along with direct links to the FDA official database.
private funding
Public funding
.png)
Want to invest in a more holistic understanding
of net treatment benefit?
Get in touch